Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 774
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Boston MA, New Haven CT, Manhasset NY, Rosedale NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
for
Duchene Muscular Dystrophy
Location: Boston MA, Worcester MA, New York NY,
Sponsor: ITF Therapeutics LLC
Sex: All
Age: 6+
Code: NCT07127978
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Location: Philadelphia PA, Washington D.C. DC, Miami FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07091630
Phase 3, Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Washington D.C. DC, Charlotte NC, Columbus OH,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
for
Autism, Autism Spectrum Disorder
Location: Washington D.C. DC
Sponsor: American University
Sex: All
Age: 18 - 35
Code: NCT05396352
Recruiting
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
for
Violence Risk, Early Psychosis
Location: Washington D.C. DC
Sponsor: Howard University
Sex: All
Age: 16 - 30
Code: NCT07417904
Recruiting
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Burlington MA, New York NY, Philadelphia PA,
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07023614
Phase 2, Recruiting
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
for
Short Bowel Syndrome
Location: Boston MA, Washington D.C. DC, Cincinnati OH,
Sponsor: Eclipse Regenesis, Inc.
Sex: All
Age: 0 - 65
Code: NCT05535361
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Boston MA, New Haven CT, Sherbrooke, New York NY,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase 3, Recruiting
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 1 - 8
Code: NCT06188741
Phase 2, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Staten Island NY, Washington D.C. DC,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Hershey PA, Washington D.C. DC, Miami FL, Charleston SC,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase 3, Recruiting
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials